Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

şimdi satın al

Indir Ürün özellikleri (SPC)
28-02-2019

Aktif bileşen:

Enrofloxacin

Mevcut itibaren:

Emdoka bvba

ATC kodu:

QJ01MA90

INN (International Adı):

Enrofloxacin

Doz:

50 milligram(s)/millilitre

Farmasötik formu:

Solution for injection

Reçete türü:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapötik alanı:

enrofloxacin

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2013-09-27

Ürün özellikleri

                                Health Products Regulatory Authority
27 February 2019
CRN008W34
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and
Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of the solution for injection contains:
ACTIVE SUBSTANCE:MG
Enrofloxacin 50
EXCIPIENTS:
Butyl alcohol as antimicrobial preservative 30
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, light yellow, sterile, aqueous solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (calves)
Pigs weighing more than 25kg
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida,
Mannheimia_
_haemolytica _and _Mycoplasma _spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of _Mycoplasma bovis_.
Pigs
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida, Mycoplasma
_
spp. and _Actinobacillus pleuropneumoniae_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli. _
Dogs
Treatment of infections of the alimentary, respiratory and urogenital
tracts (including prostatitis, adjunctive antibiotic therapy
for pyometra), skin and wound infections, otitis (externa/media)
caused by enrofloxacin susceptible strains of _Staphylococcus _
spp_., Escherichia coli, Pasteurella _spp_., Klebsiella _spp_.,
Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_. _
Cats
Treatment of infections of the alimentary, respiratory and uroge
                                
                                Belgenin tamamını okuyun
                                
                            

Bu ürünle ilgili arama uyarıları